Clinical translation of gene expression profiling in lymphomas and leukemias

Harris, 2000, Lymphoma classification—From controversy to consensus: The R.E.A.L. and WHO classification of lymphoid neoplasms, Ann Oncol, 11, 3, 10.1093/annonc/11.suppl_1.S3

Harris, 1994, A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361

2001

Staudt, 2000, Genomic views of the immune system, Ann Rev Immunol, 18, 829, 10.1146/annurev.immunol.18.1.829

Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, 403, 503, 10.1038/35000501

Damle, 1999, Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia, Blood, 94, 1840, 10.1182/blood.V94.6.1840

Rosenwald, 2001, Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia, J Exp Med, 194, 1639, 10.1084/jem.194.11.1639

Coiffier, 2001, Diffuse large cell lymphoma, Curr Opin Oncol, 13, 325, 10.1097/00001622-200109000-00003

Fisher, 2000, Diffuse large-cell lymphoma, Ann Oncol, 11, 29, 10.1093/annonc/11.suppl_1.S29

Brittinger, 1984, Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas: Results of a prospective multicenter study by the Kiel Lymphoma Study Group, Hematol Oncol, 2, 269, 10.1002/hon.2900020306

Melnyk, 1997, Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma, Blood, 89, 4514, 10.1182/blood.V89.12.4514

Salar, 1998, Diffuse large B-cell lymphoma: Is morphologic subdivision useful in clinical management?, Eur J Haematol, 60, 202, 10.1111/j.1600-0609.1998.tb01023.x

The International Non-Hodgkin's Lymphoma Prognostic Factors Project, 1993, A predictive model for aggressive non-Hodgkin's lymphoma, N Engl J Med, 329, 987, 10.1056/NEJM199309303291402

Shaffer, 2001, Signatures of the immune response, Immunity, 15, 375, 10.1016/S1074-7613(01)00194-7

Lossos, 2000, Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas, Proc Natl Acad Sci USA, 97, 10209, 10.1073/pnas.180316097

Caligaris-Cappio, 2000, Biology of chronic lymphocytic leukemia, Rev Clin Exp Hematol, 4, 5, 10.1046/j.1468-0734.2000.00001.x

Golub, 1999, Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring, Science, 286, 531, 10.1126/science.286.5439.531

Davis, 2001, Constitutive NF-κB activity is required for survival of activated B-like diffuse large B-cell lymphoma cells, J Exp Med, 194, 1861, 10.1084/jem.194.12.1861

Baldwin, 2001, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB, J Clin Invest, 107, 241, 10.1172/JCI11991